Friday, January 29, 2021 10:25:08 PM
Indeed. Perhaps they also decided that once the R/S, and the ticker chage and getting our shares back was done, that once they had finalized the CCA, LLC R/M and a 40 Mil cash underwritten offering at $4, and actually completed that part, it was finally time to put the 1.0 version of the website.
Then we got the version 2.0 website upgrade with Mathias and Mark Kester added, shortly before we apparently bought most of Keystone Nano. And shortly after the Keystone Nano shares were issued to buy part of Keystone Nano?
I had to do a lot of digging and research paper reading to discover that the LSD disease addition to the website when Kestor Was added, was a Kester technology using Ceramides, that in our case could be useful for all manner of illnesses including ones in the brain, like TBI etc.....
There job was to build a 10 billion dollar biotech in the dark, in a dark, fully non reporting OTC shell, they thought no one pay much attention to or figure out until they turned the lights on with the SEC filings.
Imagine if the CEO had pushed the stock price and the SEC had suspended and revoked the shares? That could have happened had Hovis been talking and pushing the stock as an investment to the retail public before the filings. Because the 15-12g filing 12 years ago made it legally dark and non reporting.
Also imagine if the stock went to and held $10 share while they were doing a $4/share deal with both biotechs, officers, directors, and the cash offering?
If I am right they wanted an even playing field as they built a massive new biotech double merger biotech in the dark?
So legally, and business wise they could not legally or business try to move the stock price higher, IMHO.
Obviously some of that is speculation, but most of it is what I would have done, thinking back.
I missed the R/S because they had way bigger serious plans and nanotech they were bringing in that I thought, and the only way to drop a 500 Million dollar biotech asset book value base into the company right away was to make room in the OS.
Have a great weekend folks.
Then we got the version 2.0 website upgrade with Mathias and Mark Kester added, shortly before we apparently bought most of Keystone Nano. And shortly after the Keystone Nano shares were issued to buy part of Keystone Nano?
I had to do a lot of digging and research paper reading to discover that the LSD disease addition to the website when Kestor Was added, was a Kester technology using Ceramides, that in our case could be useful for all manner of illnesses including ones in the brain, like TBI etc.....
There job was to build a 10 billion dollar biotech in the dark, in a dark, fully non reporting OTC shell, they thought no one pay much attention to or figure out until they turned the lights on with the SEC filings.
Imagine if the CEO had pushed the stock price and the SEC had suspended and revoked the shares? That could have happened had Hovis been talking and pushing the stock as an investment to the retail public before the filings. Because the 15-12g filing 12 years ago made it legally dark and non reporting.
Also imagine if the stock went to and held $10 share while they were doing a $4/share deal with both biotechs, officers, directors, and the cash offering?
If I am right they wanted an even playing field as they built a massive new biotech double merger biotech in the dark?
So legally, and business wise they could not legally or business try to move the stock price higher, IMHO.
Obviously some of that is speculation, but most of it is what I would have done, thinking back.
I missed the R/S because they had way bigger serious plans and nanotech they were bringing in that I thought, and the only way to drop a 500 Million dollar biotech asset book value base into the company right away was to make room in the OS.
Have a great weekend folks.
Recent NDTP News
- NDT Pharmaceuticals Highlights Enhanced Omni-Channel Positioning; Sets Stage for 2026 Growth with Strategic Marketing Expansion • GlobeNewswire Inc. • 03/03/2026 01:00:00 PM
- NDT Pharmaceuticals Inc.’s Wholly Owned Subsidiary, Good Salt Life, Receives Official Green Seal® Certification for Clean Republic Multipurpose Disinfectant • GlobeNewswire Inc. • 02/05/2026 02:00:00 PM
- NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., to Launch Dog Gone Odor® on Chewy and Amazon, Expanding its Rapidly Growing Biosafety Catalog • GlobeNewswire Inc. • 01/14/2026 01:00:00 PM
- NDT Pharmaceuticals, Inc.’s wholly owned subsidiary, Good Salt Life, Inc., Advances into AI-Robotics for Unmanned Hospital Disinfection • GlobeNewswire Inc. • 01/12/2026 01:00:00 PM
- NDT Pharmaceuticals’ Wholly Owned Subsidiary Good Salt Life, Inc. Advances Toward Key Regulatory Milestones for Clean Republic® Multipurpose Disinfectant • GlobeNewswire Inc. • 01/08/2026 01:00:00 PM
- NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., Launches Brands PurrGuard® and Dog Gone Odor®, EPA-registered Odor-killing Bacteria Chemistry for Companion Animals • GlobeNewswire Inc. • 12/19/2025 01:36:01 PM
- Good Salt Life, Inc.'s Induction Charge Delivery Systems Deployed to Protect Show Horses from Widespread EHV-1 Outbreak • ACCESS Newswire • 11/26/2025 01:00:00 PM
- NDT Pharmaceuticals' Subsidiary, Good Salt(TM) Life, Secures Major Government Contract, Deploying Advanced Biosafety Ecosystem in Tennessee State Prisons • ACCESS Newswire • 11/24/2025 02:00:00 PM
- FatPipe, Jackpot Digital, and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV • ACCESS Newswire • 11/07/2025 02:00:00 PM
- 60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV • ACCESS Newswire • 10/31/2025 01:00:00 PM
- Join NDT Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on November 5 • ACCESS Newswire • 10/30/2025 12:30:00 PM
- NDT Pharmaceuticals Showcases Strategic Value of Good Salt(TM) Life Acquisition with Expanded Relationship with Norwegian Cruise Line • ACCESS Newswire • 10/21/2025 12:30:00 PM
- Baptist Hospital Enhances Patient Safety and Air Quality with Good Salt(TM) Life's ByoCart(TM) Disinfection System • ACCESS Newswire • 10/13/2025 12:30:00 PM
- Good Salt Life Expands EPA Registrations and Anticipates New Milestone • ACCESS Newswire • 10/09/2025 12:30:00 PM
- NDT Pharmaceuticals' Good Salt(TM) Life Subsidiary Unveils Scalable Antimicrobial Platform to Drive Health, Safety, and Sustainability Across Global Markets • ACCESS Newswire • 09/23/2025 01:10:00 PM
